This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brayton, C. Articles by Montgomery, C. A. Search for Related Content PubMed PubMed Citation Articles by Brayton, C. Articles by Montgomery, C. A. Social Bookmarking                            What's this?

Evaluating Mutant Mice: Anatomic Pathology

Baylor College of Medicine, Houston, TX (CB, MJ); and Lexicon Genetics, Woodlands, TX (CAM)

As the human and mouse genome projects approach their goals, initiatives in functional genomics are advancing. When the nucleotide sequences are available, identification of gene functions will assume even greater importance. Determination of gene products and their proximal biochemical functions provide a part of the picture, but determination of their functions in the context of the whole organism is the ultimate goal. The manipulated mouse genome has become accepted as a model for understanding the genetic basis of human conditions and diseases. Consequently, biomedical research institutions have seen significant increases in the use of mice since the early 1980s, and these increases are largely attributable to the use of genetically modified mice. The role of comparative pathology in research on mutant mouse models of disease is increasing in response to these trends. Evaluation and phenotypic characterization of mutant mice, via clinical and anatomic pathology techniques, will be an important component of functional genomics initiatives.

Key words: Anatomy; histology; inbred mice; knockout mice; mutants; pathology; transgenics.

Request reprints from Dr. C. Brayton, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 (USA). E-mail cbrayton{at}bcm.tmc.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. Li, H. Wen, C. Brayton, P. Das, L. A. Smithson, A. Fauq, X. Fan, B. J. Crain, D. L. Price, T. E. Golde, et al. Epidermal Growth Factor Receptor and Notch Pathways Participate in the Tumor Suppressor Function of {gamma}-Secretase J. Biol. Chem., November 2, 2007; 282(44): 32264 - 32273. [Abstract] [Full Text] [PDF]

				T. Li, H. Wen, C. Brayton, F. M. Laird, G. Ma, S. Peng, L. Placanica, T. C. Wu, B. J. Crain, D. L. Price, et al. Moderate Reduction of {gamma}-Secretase Attenuates Amyloid Burden and Limits Mechanism-Based Liabilities J. Neurosci., October 3, 2007; 27(40): 10849 - 10859. [Abstract] [Full Text] [PDF]

				C. L. Scudamore and S. H. Smith Future Directions in Training Veterinarians for Careers in Toxicological Pathology in the United Kingdom J Vet Med Educ, January 1, 2007; 34(4): 450 - 457. [Abstract] [Full Text] [PDF]

				J. P. Sundberg Vet. Pathol., March 1, 2003; 40(2): 222 - 222. [Full Text] [PDF]

				J. M. Spitsbergen and M. L. Kent The State of the Art of the Zebrafish Model for Toxicology and Toxicologic Pathology Research--Advantages and Current Limitations Toxicol Pathol, January 1, 2003; 31(1_suppl): 62 - 87. [Abstract] [PDF]